Liver damage (decreased albumin and increased globulin) in patients with COVID-19 infections might be associated with the direct effect of the viral infection of liver cells, drug hepatotoxicity, or immune-mediated inflammation (37), such as cytokine storm and pneumonia-associated hypoxia. Here, ALB is linked to susceptibility to pneumonia measurement.